Compare SCLX & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | FRD |
|---|---|---|
| Founded | 2011 | 1965 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.6M | 134.3M |
| IPO Year | N/A | 1995 |
| Metric | SCLX | FRD |
|---|---|---|
| Price | $8.82 | $16.76 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 29.2K | 23.3K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | N/A | ★ $121,157,278.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $749.70 | N/A |
| P/E Ratio | ★ N/A | $11.95 |
| Revenue Growth | N/A | ★ 55.82 |
| 52 Week Low | $0.18 | $12.24 |
| 52 Week High | $34.27 | $24.37 |
| Indicator | SCLX | FRD |
|---|---|---|
| Relative Strength Index (RSI) | 51.43 | 30.99 |
| Support Level | $7.73 | $16.58 |
| Resistance Level | $9.00 | $17.03 |
| Average True Range (ATR) | 0.65 | 0.70 |
| MACD | 0.23 | -0.15 |
| Stochastic Oscillator | 62.68 | 4.79 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.